Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
The company's lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. It also develops CLR 121125, an iodine-125 Auger-emitting radioconjugate program; and CLR 225, an actinium-225 based radioconjugate program. The company has collaborative with Orano Med to develop alpha emitter lead-212 conjugated to phospholipid ether series; and LegoChem Bio. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.
Company profile from EODHD, stored Oct 29, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 13, 2026 | — | — | — | -$7.2M | -$6.9M |
| Mar 2026filed May 14, 2026 | — | — | — | -$5.8M | -$5.7M |
| Dec 2025filed Mar 4, 2026 | — | — | — | -$5.7M | -$5.3M |
| Sep 2025filed Nov 13, 2025 | — | — | — | -$4.9M | -$4.4M |
| Jun 2025filed Aug 14, 2025 | — | — | — | -$6.0M | -$5.4M |
| Mar 2025filed May 13, 2025 | — | — | — | -$6.4M | -$6.6M |
| Dec 2024filed Mar 13, 2025 | $309.0K | -6.5% | 50.0% | -$12.7M | -$2.4M |
| Sep 2024filed Nov 18, 2024 | — | — | — | -$13.3M | -$14.7M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 4, 2026 | — | — | — | -$23.0M | -$21.8M |
| Dec 2024filed Mar 13, 2025 | — | — | — | -$51.8M | -$44.6M |
| Dec 2023filed Mar 27, 2024 | — | — | — | -$39.0M | -$42.8M |
| Dec 2022filed Mar 9, 2023 | — | — | — | -$28.8M | -$28.6M |
| Dec 2021filed Mar 21, 2022 | — | — | — | -$24.1M | -$24.0M |
| Dec 2020filed Mar 2, 2021 | — | — | — | -$15.3M | -$15.1M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched CLRB. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
263,517 shares short
+97,252 shares (+58.5%) vs Sep 30, 2026
2.8% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
166,265 shares short
-24,863 shares (-13%) vs Sep 15, 2026
1.8% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
191,128 shares short
+24,143 shares (+14.5%) vs Aug 31, 2026
2.4% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
166,985 shares short
+5,788 shares (+3.6%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
161,197 shares short
-13,632 shares (-7.8%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
174,829 shares short
-24,607 shares (-12.3%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind CLRB’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
1 for 30 · reverse split
Effective Jun 24, 2025
Each 30 pre-split shares become 1 post-split share.
Source: EODHD
1 for 10 · reverse split
Effective Jul 22, 2022
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
1 for 10 · reverse split
Effective Jul 17, 2018
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
1 for 10 · reverse split
Effective Mar 7, 2016
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
1 for 20 · reverse split
Effective Jun 16, 2014
Each 20 pre-split shares become 1 post-split share.
Source: EODHD
1 for 153 · reverse split
Effective Apr 11, 2011
Each 153 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if CLRB is in your portfolio and how much it contributes.
Sign inLoading market dates
12 smart-money holders: institutions with a high Holder IQ
Sentiment: unknown
No recent insider trades detected.
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 0
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
29 filers reported a long position in CLRB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
86%
of the 3.3M shares 13-F filers reported
Moves vs Q1 2026
2 added0 trimmed
7 new · 1 not comparable
Net shares held
+238.7%
across the 2 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Caligan Partners LP | $1.3M · 470K shares | 470K | New |
| 2 | STEMPOINT CAPITAL LP | $986.7K · 354.9K shares | 354.9K | New |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $910.1K · 327.4K shares | 327.4K | +299.8% |
| 4 | SILVERARC CAPITAL MANAGEMENT, LLC | $894.4K · 321.7K shares | 321.7K | New |
| 5 | Bleichroeder LP | $802.5K · 288.7K shares | 288.7K | +188.7% |
| 6 | Jupiter Topco LLC | $759.4K · 274.2K shares | 274.2K | — |
| 7 | BALYASNY ASSET MANAGEMENT L.P. | $611.6K · 220K shares | 220K | New |
| 8 | Nantahala Capital Management, LLC | $611.6K · 220K shares | 220K | New |
| 9 | Empery Asset Management, LP | $527.1K · 189.6K shares | 189.6K | New |
| 10 | DIADEMA PARTNERS LP | $384.6K · 138.3K shares | 138.3K | New |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inHolders of more than 5% of CLRB file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 14, 2026 | Caligan Partners LP13G · passive | 5.9% |
| Aug 14, 2026 | BALYASNY ASSET MANAGEMENT L.P.13G · passive | 9.99% |
| Aug 14, 2026 | SILVERARC CAPITAL MANAGEMENT, LLC13G · passive | 9.99% |
| Aug 14, 2026 | STEMPOINT CAPITAL LP13G · passive | 9.9% |
| Aug 13, 2026 | Bleichroeder LP13G · passive | 9.99% |
| Aug 4, 2026 | Empery Asset Management, LP13G · passive | 9.99% |
| Jun 5, 2026 | JANUS HENDERSON GROUP PLC13G · passive | 9.99% |
| May 11, 2026 | Stonepine Capital Management, LLC13G · passive | 9.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.